Patient Group Direction for Comirnaty® Original/Omicron BA.1 (15/15 micrograms)/dose COVID-19 mRNA vaccine

Document first published:
Page updated:
Topic:
Publication type:

This Patient Group Direction (PGD) is for the administration of Comirnaty® Original/Omicron BA.1 (15/15 micrograms)/dose COVID-19 mRNA vaccine to individuals 12 years of age and over as a booster dose in accordance with the national COVID-19 vaccination programme.

Summary

Providers must check that they are using the current version of the PGD. Amendments may become necessary prior to the published expiry date.

Published 22 September 2022.

Summary

Providers must check that they are using the current version of the PGD. Amendments may become necessary prior to the published expiry date.

Published 22 September 2022.